STIM on XNAS, Health Care, Neuronetics, Inc., job postings
Measures activity, not value. Not investment advice.
Revenue rose 23% to $159.8M over twelve months while shares fell 38% in a month.
BadInsiders sold $4.5M and bought $120K in the last 90 days
BadNet loss of $23.1M over twelve months, with debt of $61.8M
Written by AI from the data on this page, 22 Nov 2026. Not investment advice.
Profile and fundamentals
From its SEC filings, 12 months to 30 Sep 2026
Neuronetics Inc a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advance Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advance Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address the existing treatment options. The company operates in two segments: medical devices and clinic services.
Industry
Surgical & medical instruments & apparatus (Health Care)
expected around 9 Feb 2027 (an estimate: a year ago it reported on 10 Feb 2026)
Revenue and net income per quarter. Quarter to 30 Sep 2026: revenue $42.1M, net loss $1.7M.
31 Dec 2021RevenueNet incomeNet losstallest bar $42.1M30 Sep 2026
See the numbers
Quarter to
Revenue
Net income
30 Sep 2026
$42.1M
-$1.7M
30 Jun 2026
$41.6M
-$3.4M
31 Mar 2026
$34.5M
-$10.8M
31 Dec 2025
$41.8M
-$7.2M
30 Sep 2025
$37.4M
-$9.0M
30 Jun 2025
$38.2M
-$10.1M
31 Mar 2025
$32.0M
-$12.7M
31 Dec 2024
$22.5M
-$12.7M
30 Sep 2024
$18.6M
-$13.3M
30 Jun 2024
$16.5M
-$9.8M
31 Mar 2024
$17.4M
-$7.9M
31 Dec 2023
$20.4M
-$5.4M
30 Sep 2023
$17.9M
-$9.4M
30 Jun 2023
$17.6M
-$4.9M
31 Mar 2023
$15.6M
-$10.5M
31 Dec 2022
$18.2M
-$8.3M
30 Sep 2022
$16.6M
-$7.6M
30 Jun 2022
$16.4M
-$10.4M
31 Mar 2022
$14.2M
-$10.8M
31 Dec 2021
$15.1M
-$7.6M
Fundamentals, 12 months to 30 Sep 2026
Measure
Latest
Year before
Peer median
RevenueiSales over the last 12 months reported.
$160.0M
$130.1M
Revenue growthiRevenue of the last 12 months compared with the 12 months before.
+23%
+13%
Net incomeiProfit after all costs and taxes over the last 12 months reported. Negative is a loss.
-$23.1M
-$44.5M
EPS (diluted)iEarnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split).
-$0.33
-$0.83
Gross marginiWhat is left of each dollar of sales after the direct cost of making the product or service.
50.6%
50.4%
60.5%
Operating marginiOperating income as a share of sales: profit from the business before interest and taxes.
-9.4%
-29.1%
-8.3%
Net marginiNet income as a share of sales: what the owners keep of each dollar sold.
-14.4%
-34.2%
-10.1%
Return on equityiNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money.
-100%
-26.3%
Free cash flowiCash from operations minus capital spending over the last 12 months: cash the business produced.
-$9.6M
-$30.6M
CashiCash, cash equivalents and short-term investments on the latest balance sheet.
$22.1M
$28.0M
DebtiShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted.
$61.8M
$65.7M
Net debtiDebt minus cash. Negative means the company holds more cash than it owes (net cash).
$39.6M
$37.7M
Debt to equityiDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative.
3.3
0.31
Book value per shareiShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding.
$0.24
P/EiPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss.
loss
28.0
P/SiPrice to sales: market cap divided by revenue of the last 12 months.
0.61
2.3
EV/SalesiEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months.
0.86
2.5
P/BiPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative.
5.2
2.8
Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.
Peers nearest by market cap, its own industry first
Insider Buy/Sell iShares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.
-$4.4M
bought $120K, sold $4.5M
Institutional holders iThe number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.
+9.3%
94 13F filers vs 86
Institutional ownership iShares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.
58%
44.9M shares held by 13F filers (30 Sep 2026) of 77.7M outstanding (28 Oct 2026)
Short interest iShares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.
8.6%
6.7M shares sold short (30 Oct 2026) of 77.7M outstanding (28 Oct 2026)
Days to cover iShort interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.
9.9
6.7M shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it
Short interest change iHow the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.
-7.6%
7.2M shares sold short in the report before, 6.7M on 30 Oct 2026
Short sale volume iShare of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.
34%
34% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 43%
Open jobs iJob postings open on the company's own careers site today, where we track it. Blank when we do not track this company's careers site yet.
–
We do not track this company's careers site yet.
Open jobs change iHow the number of open job postings changed over the last 30 days: total hiring demand, any job, any country. Shown only once we have tracked the company for 30 days.
–
We do not track this company's careers site yet.
Employees iTotal staff the company reported in its latest annual report (10-K), with the change from the year before when both years are reported.
–
No headcount in its annual reports in our data.
Visa hiring (foreign workers) iApplications to hire foreign specialists on H-1B and E-3 visas certified by the Labor Department in the last 12 months, compared with the 12 months before. This is NOT total hiring: most hires need no visa. Open jobs shows total hiring where we track it.
–
No data for this company
Revenue growth iSales in the latest reported quarter compared with the same quarter a year earlier.
+13%
$42.1M vs $37.4M (quarter ended 30 Sep 2026)
Capital spending iMoney spent on buildings, machines and equipment in the latest quarter, compared with the same quarter a year earlier.
–
No data for this company
Federal contracts iMoney the US government committed to the company in contracts and grants over the last 12 months.
–
No data for this company
Lobbying iWhat the company reported spending on federal lobbying over the last four quarters.
–
No data for this company
Layoff notices iWorkers named in state WARN layoff notices over the last 12 months (employers must file them 60 days before a large layoff).
–
No data for this company
News (7d) iArticles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.
12
12 articles in the last 7 days; its usual week has 1 (the median of the 26 weeks before).
News vs usual iArticles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.
12×
12 articles in the last 7 days; its usual week has 1.
Price $1.25 on 20 Nov 2026, -3.8% over 12 months (12-month range $1.18 to $3.30)
Sharp change
8-K and other filings
Lobbying filing
Insider net buying (open market). Insiders bought a net $181K in the last 12 months (the 12 months before: -$14.5M).Revenue per quarter. Revenue $42.1M in the latest quarter, +13% on a year earlier.Capital spending per quarter. Capital spending $470K in the latest quarter, +312% on a year earlier.Institutional holders (13F filers). 94 13F filers reported holding it in the latest 13F quarter, -1.1% on a year earlier.Federal obligations. Federal obligations: -$40K published in the last 12 months (none in the 12 months before).Lobbying spend. Lobbying spend: $0 published in the last 12 months.
Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: h-1b/e-3 applications certified, workers in warn layoff notices.
Quarter ended 31 Dec 2021: $15.1M, -2.9% on a year earlier; public on 9 Mar 2022
Quarter ended 31 Mar 2022: $14.2M, +15% on a year earlier; public on 13 May 2022
Quarter ended 30 Jun 2022: $16.4M, +15% on a year earlier; public on 3 Aug 2022
Quarter ended 30 Sep 2022: $16.6M, +20% on a year earlier; public on 9 Nov 2022
Quarter ended 31 Dec 2022: $18.2M, +20% on a year earlier; public on 8 Mar 2023
Quarter ended 31 Mar 2023: $15.6M, +9.5% on a year earlier; public on 16 May 2023
Quarter ended 30 Jun 2023: $17.6M, +7.8% on a year earlier; public on 9 Aug 2023
Quarter ended 30 Sep 2023: $17.9M, +8.1% on a year earlier; public on 8 Nov 2023
Quarter ended 31 Dec 2023: $20.4M, +12% on a year earlier; public on 9 Mar 2024
Quarter ended 31 Mar 2024: $17.4M, +12% on a year earlier; public on 8 May 2024
Quarter ended 30 Jun 2024: $16.5M, -6.6% on a year earlier; public on 13 Aug 2024
Quarter ended 30 Sep 2024: $18.6M, +3.7% on a year earlier; public on 13 Nov 2024
Quarter ended 31 Dec 2024: $22.5M, +10% on a year earlier; public on 28 Mar 2025
Quarter ended 31 Mar 2025: $32.0M, +84% on a year earlier; public on 7 May 2025
Quarter ended 30 Jun 2025: $38.2M, +132% on a year earlier; public on 6 Aug 2025
Quarter ended 30 Sep 2025: $37.4M, +101% on a year earlier; public on 5 Nov 2025
Quarter ended 31 Dec 2025: $41.8M, +86% on a year earlier; public on 18 Mar 2026
Quarter ended 31 Mar 2026: $34.5M, +7.8% on a year earlier; public on 6 May 2026
Quarter ended 30 Jun 2026: $41.6M, +9.1% on a year earlier; public on 12 Aug 2026
Quarter ended 30 Sep 2026: $42.1M, +13% on a year earlier; public on 5 Nov 2026
Capital spending per quarter
Quarter ended 31 Dec 2021: $801K, +597% on a year earlier; public on 9 Mar 2022
Quarter ended 31 Mar 2022: $1.1M, +59% on a year earlier; public on 13 May 2022
Quarter ended 30 Jun 2022: $966K, +123% on a year earlier; public on 3 Aug 2022
Quarter ended 30 Sep 2022: $726K, +64% on a year earlier; public on 9 Nov 2022
Quarter ended 31 Dec 2022: $503K, -37% on a year earlier; public on 8 Mar 2023
Quarter ended 31 Mar 2023: $234K, -78% on a year earlier; public on 16 May 2023
Quarter ended 30 Jun 2023: $704K, -27% on a year earlier; public on 9 Aug 2023
Quarter ended 30 Sep 2023: $552K, -24% on a year earlier; public on 8 Nov 2023
Quarter ended 31 Dec 2023: $879K, +75% on a year earlier; public on 9 Mar 2024
Quarter ended 31 Mar 2024: $375K, +60% on a year earlier; public on 8 May 2024
Quarter ended 30 Jun 2024: $616K, -12% on a year earlier; public on 13 Aug 2024
Quarter ended 30 Sep 2024: $386K, -30% on a year earlier; public on 13 Nov 2024
Quarter ended 31 Dec 2024: $89K, -90% on a year earlier; public on 28 Mar 2025
Quarter ended 31 Mar 2025: $219K, -42% on a year earlier; public on 7 May 2025
Quarter ended 30 Jun 2025: $252K, -59% on a year earlier; public on 6 Aug 2025
Quarter ended 30 Sep 2025: $114K, -70% on a year earlier; public on 5 Nov 2025
Quarter ended 31 Dec 2025: $216K, +143% on a year earlier; public on 18 Mar 2026
Quarter ended 31 Mar 2026: $197K, -10% on a year earlier; public on 6 May 2026
Quarter ended 30 Jun 2026: $417K, +65% on a year earlier; public on 12 Aug 2026
Quarter ended 30 Sep 2026: $470K, +312% on a year earlier; public on 5 Nov 2026
Institutional holders (13F filers)
31 Dec 2021 report: 75; public on 14 Feb 2022
31 Mar 2022 report: 80; public on 16 May 2022
30 Jun 2022 report: 75; public on 15 Aug 2022
30 Sep 2022 report: 74; public on 14 Nov 2022
31 Dec 2022 report: 80; public on 14 Feb 2023
31 Mar 2023 report: 72; public on 15 May 2023
30 Jun 2023 report: 66; public on 14 Aug 2023
30 Sep 2023 report: 54; public on 14 Nov 2023
31 Dec 2023 report: 65; public on 14 Feb 2024
31 Mar 2024 report: 66; public on 15 May 2024
30 Jun 2024 report: 65; public on 14 Aug 2024
30 Sep 2024 report: 48; public on 14 Nov 2024
31 Dec 2024 report: 44; public on 14 Feb 2025
31 Mar 2025 report: 98; public on 15 May 2025
30 Jun 2025 report: 86; public on 14 Aug 2025
30 Sep 2025 report: 95; public on 14 Nov 2025
31 Dec 2025 report: 92; public on 17 Feb 2026
31 Mar 2026 report: 95; public on 15 May 2026
30 Jun 2026 report: 86; public on 14 Aug 2026
30 Sep 2026 report: 94; public on 16 Nov 2026
Federal obligations
Month from 1 Nov 2021: $75K published
Month from 1 Dec 2021: $93K published
Month from 1 Jan 2022: $5K published
Month from 1 Feb 2022: $10K published
Month from 1 Mar 2022: $24K published
Month from 1 Apr 2022: $5K published
Month from 1 May 2022: $0 published
Month from 1 Jun 2022: $274K published
Month from 1 Aug 2022: $38K published
Month from 1 Sep 2022: $22K published
Month from 1 Oct 2022: $5K published
Month from 1 Nov 2022: $10K published
Month from 1 Dec 2022: $28K published
Month from 1 Mar 2023: $5K published
Month from 1 Jun 2023: $5K published
Month from 1 Aug 2023: $280K published
Month from 1 Oct 2023: $5K published
Month from 1 Dec 2023: $10K published
Month from 1 Mar 2024: $5K published
Month from 1 May 2024: $11K published
Month from 1 Jun 2024: $0 published
Month from 1 Aug 2024: $5K published
Month from 1 Oct 2024: $274K published
Month from 1 Dec 2024: -$297K published
Month from 1 Feb 2025: $5K published
Month from 1 Jun 2025: -$167K published
Month from 1 Aug 2025: $176K published
Month from 1 Oct 2025: -$5K published
Month from 1 Dec 2025: $15K published
Month from 1 May 2026: $0 published
Month from 1 Aug 2026: -$56K published
Month from 1 Sep 2026: $0 published
Lobbying spend
Quarter from 1 Oct 2023: $30K published
Quarter from 1 Jan 2024: $45K published
Quarter from 1 Apr 2024: $45K published
Quarter from 1 Jul 2024: $45K published
What is unusual now
Nothing unusual in the last 90 days: no change appeared. Its most unusual measure now is insider open-market selling (USD, Form 4) at $4.5M (13 Nov 2026), higher than 99% of its own history.
Entered Amendment No. 6 to credit agreement with Perceptive Credit Holdings IV, LP; modifies revenue covenants, conditioned on $15M prepayment by Nov 30, 2026
Reported lobbying spend: $45K in Q2 2024, $45K in Q1 2024. Rows are lobbying firms hired or let go; amounts are reported per quarter, not per firm here.
Date
Change
Lobbying firm
Issue
Source
27 Oct 2025
New
Checkmate Government Relationsfor Neuronetics, Inc.
Two or more unrelated kinds of records unusual within 30 days
7 Aug 2025confirmed
Confirmed across sources Institutional holdings and Filings + Financials and Short interest and volume
Neuronetics(STIM): had 4.7M shares sold short in the 15 Jul 2025 report, 35× the same report last year; it also reported revenue of $38.1M for the quarter ended 30 Jun 2025, 2.3× the same quarter last year; and it saw 21 13F filers open a new position in the quarter ended 30 Jun 2025, 3.0× the same quarter last year. Three unrelated kinds of activity within 16 days.
Short interest and volume: Short interest spike, became public on 25 Jul 2025
Financials: Quarterly revenue change, became public on 7 Aug 2025
Institutional holdings: Many funds opening a new position, became public on 14 Aug 2025
The 15 Jul 2025 report against the 24 reports before it.
this reportearliernormal: 1.1MSee the evidence (3 changes)
Short interest and volume: Short interest spike became public on 25 Jul 2025
Neuronetics had 4.7M shares sold short in the 15 Jul 2025 report, 35× the same report last year.
This period
4.7M (the 15 Jul 2025 report)
Normal report (median of 24 earlier)
1.1M
Typical spread (median absolute deviation)
660K
How far from its usual level
+3.7
Same report last year
134K
History used
2,559 days
the 15 Jul 2025 report24 earlier reportsnormal: 1.1M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Financials: Quarterly revenue change became public on 7 Aug 2025
Neuronetics reported revenue of $38.1M for the quarter ended 30 Jun 2025, 2.3× the same quarter last year.
This period
$38.1M (the quarter ended 30 Jun 2025)
Normal quarter (median of 8 earlier)
$18.2M
Typical spread (median absolute deviation)
$1.3M
How far from its usual level
+10.5
Same quarter last year
$16.4M
History used
3,013 days
the quarter ended 30 Jun 20258 earlier quartersnormal: $18.2M
Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.
Institutional holdings: Many funds opening a new position became public on 14 Aug 2025
Neuronetics saw 21 13F filers open a new position in the quarter ended 30 Jun 2025, 3.0× the same quarter last year.
This period
21 (the quarter ended 30 Jun 2025)
Normal quarter (median of 8 earlier)
8
Typical spread (median absolute deviation)
2.5
How far from its usual level
+3.5
Same quarter last year
7
History used
2,557 days
the quarter ended 30 Jun 20258 earlier quartersnormal: 8
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.
Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.
8 May 2025confirmed
Confirmed across sources Institutional holdings and Filings + Financials and Short interest and volume
Neuronetics(STIM): reported revenue of $32.0M for the quarter ended 31 Mar 2025, 1.8× the same quarter last year; it also had 3.7M shares sold short in the 30 Apr 2025 report, 63× the same report last year; and it saw 55 13F filers open a new position in the quarter ended 31 Mar 2025, 5.0× the same quarter last year. Three unrelated kinds of activity within 30 days.
Short interest and volume: Short interest spike, became public on 10 Apr 2025
Short interest and volume: Short interest spike, became public on 26 Apr 2025
Financials: Quarterly revenue change, became public on 8 May 2025
Short interest and volume: Short interest spike, became public on 10 May 2025
Institutional holdings: Many funds opening a new position, became public on 15 May 2025
The quarter ended 31 Mar 2025 against the 8 quarters before it.
this quarterearliernormal: $17.7MSee the evidence (5 changes)
Short interest and volume: Short interest spike became public on 10 Apr 2025
Neuronetics had 3.3M shares sold short in the 31 Mar 2025 report, 35× the same report last year.
This period
3.3M (the 31 Mar 2025 report)
Normal report (median of 24 earlier)
560K
Typical spread (median absolute deviation)
446K
How far from its usual level
+4.2
Same report last year
95K
History used
2,453 days
the 31 Mar 2025 report24 earlier reportsnormal: 560K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Short interest and volume: Short interest spike became public on 26 Apr 2025
Neuronetics had 3.4M shares sold short in the 15 Apr 2025 report, 60× the same report last year.
This period
3.4M (the 15 Apr 2025 report)
Normal report (median of 24 earlier)
564K
Typical spread (median absolute deviation)
450K
How far from its usual level
+4.3
Same report last year
58K
History used
2,468 days
the 15 Apr 2025 report24 earlier reportsnormal: 564K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Financials: Quarterly revenue change became public on 8 May 2025
Neuronetics reported revenue of $32.0M for the quarter ended 31 Mar 2025, 1.8× the same quarter last year.
This period
$32.0M (the quarter ended 31 Mar 2025)
Normal quarter (median of 8 earlier)
$17.7M
Typical spread (median absolute deviation)
$1.0M
How far from its usual level
+8.0
Same quarter last year
$17.4M
History used
2,922 days
the quarter ended 31 Mar 20258 earlier quartersnormal: $17.7M
Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.
Short interest and volume: Short interest spike became public on 10 May 2025
Neuronetics had 3.7M shares sold short in the 30 Apr 2025 report, 63× the same report last year.
This period
3.7M (the 30 Apr 2025 report)
Normal report (median of 24 earlier)
586K
Typical spread (median absolute deviation)
472K
How far from its usual level
+4.4
Same report last year
58K
History used
2,483 days
the 30 Apr 2025 report24 earlier reportsnormal: 586K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Institutional holdings: Many funds opening a new position became public on 15 May 2025
Neuronetics saw 55 13F filers open a new position in the quarter ended 31 Mar 2025, 5.0× the same quarter last year.
This period
55 (the quarter ended 31 Mar 2025)
Normal quarter (median of 8 earlier)
7
Typical spread (median absolute deviation)
2
How far from its usual level
+16.0
Same quarter last year
11
History used
2,466 days
the quarter ended 31 Mar 20258 earlier quartersnormal: 7
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.
Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.
17 Aug 2021confirmed
Confirmed across sources Institutional holdings and Short interest and volume
Neuronetics(STIM): saw 28 13F filers open a new position in the quarter ended 30 Jun 2021, 2.5× the same quarter last year, while it had 2.1M shares sold short in the 13 Aug 2021 report, 3.6× the same report last year. Two unrelated kinds of activity within 49 days.
Short interest and volume: Short interest spike, became public on 27 Jul 2021
Institutional holdings: Many funds opening a new position, became public on 16 Aug 2021
Short interest and volume: Short interest spike, became public on 11 Aug 2021
Short interest and volume: Short interest spike, became public on 25 Aug 2021
Short interest and volume: Short interest spike, became public on 11 Sep 2021
The quarter ended 30 Jun 2021 against the 8 quarters before it.
this quarterearliernormal: 11See the evidence (5 changes)
Short interest and volume: Short interest spike became public on 27 Jul 2021
Neuronetics had 1.7M shares sold short in the 15 Jul 2021 report, 6.1× the same report last year.
This period
1.7M (the 15 Jul 2021 report)
Normal report (median of 24 earlier)
620K
Typical spread (median absolute deviation)
174K
How far from its usual level
+4.0
Same report last year
270K
History used
1,098 days
the 15 Jul 2021 report24 earlier reportsnormal: 620K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Institutional holdings: Many funds opening a new position became public on 16 Aug 2021
Neuronetics saw 28 13F filers open a new position in the quarter ended 30 Jun 2021, 2.5× the same quarter last year.
This period
28 (the quarter ended 30 Jun 2021)
Normal quarter (median of 8 earlier)
11
Typical spread (median absolute deviation)
2.5
How far from its usual level
+4.6
Same quarter last year
11
History used
1,096 days
the quarter ended 30 Jun 20218 earlier quartersnormal: 11
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.
Short interest and volume: Short interest spike became public on 11 Aug 2021
Neuronetics had 1.6M shares sold short in the 30 Jul 2021 report, 4.0× the same report last year.
This period
1.6M (the 30 Jul 2021 report)
Normal report (median of 24 earlier)
651K
Typical spread (median absolute deviation)
175K
How far from its usual level
+3.6
Same report last year
394K
History used
1,113 days
the 30 Jul 2021 report24 earlier reportsnormal: 651K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Short interest and volume: Short interest spike became public on 25 Aug 2021
Neuronetics had 2.1M shares sold short in the 13 Aug 2021 report, 3.6× the same report last year.
This period
2.1M (the 13 Aug 2021 report)
Normal report (median of 24 earlier)
699K
Typical spread (median absolute deviation)
208K
How far from its usual level
+4.4
Same report last year
569K
History used
1,127 days
the 13 Aug 2021 report24 earlier reportsnormal: 699K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Short interest and volume: Short interest spike became public on 11 Sep 2021
Neuronetics had 2.1M shares sold short in the 31 Aug 2021 report, 3.4× the same report last year.
This period
2.1M (the 31 Aug 2021 report)
Normal report (median of 24 earlier)
746K
Typical spread (median absolute deviation)
254K
How far from its usual level
+3.7
Same report last year
619K
History used
1,145 days
the 31 Aug 2021 report24 earlier reportsnormal: 746K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.
Timeline
Changes and notable records, by the date each became public
reported revenue of $41.8M for the quarter ended 31 Dec 2025, 1.9× the same quarter last year.
Same quarter last year: $22.5M; its normal quarter is $21.4M.
See the evidence
This period
$41.8M (the quarter ended 31 Dec 2025)
Normal quarter (median of 8 earlier)
$21.4M
Typical spread (median absolute deviation)
$4.5M
How far from its usual level
+3.1
Same quarter last year
$22.5M
History used
3,197 days
the quarter ended 31 Dec 20258 earlier quartersnormal: $21.4M
Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.
reported revenue of $37.3M for the quarter ended 30 Sep 2025, 2.0× the same quarter last year.
Same quarter last year: $18.5M; its normal quarter is $19.4M.
See the evidence
This period
$37.3M (the quarter ended 30 Sep 2025)
Normal quarter (median of 8 earlier)
$19.4M
Typical spread (median absolute deviation)
$2.5M
How far from its usual level
+4.8
Same quarter last year
$18.5M
History used
3,105 days
the quarter ended 30 Sep 20258 earlier quartersnormal: $19.4M
Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.
saw 21 13F filers open a new position in the quarter ended 30 Jun 2025, 3.0× the same quarter last year.
Same quarter last year: 7; its normal quarter is 8.
See the evidence
This period
21 (the quarter ended 30 Jun 2025)
Normal quarter (median of 8 earlier)
8
Typical spread (median absolute deviation)
2.5
How far from its usual level
+3.5
Same quarter last year
7
History used
2,557 days
the quarter ended 30 Jun 20258 earlier quartersnormal: 8
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.
had 4.7M shares sold short in the 15 Jul 2025 report, 35× the same report last year; it also reported revenue of $38.1M for the quarter ended 30 Jun 2025, 2.3× the same quarter last year; and it saw 21 13F filers open a new position in the quarter ended 30 Jun 2025, 3.0× the same quarter last year. Three unrelated kinds of activity within 16 days.
See the evidence (3 changes)
Short interest and volume: Short interest spike became public on 25 Jul 2025
Neuronetics had 4.7M shares sold short in the 15 Jul 2025 report, 35× the same report last year.
This period
4.7M (the 15 Jul 2025 report)
Normal report (median of 24 earlier)
1.1M
Typical spread (median absolute deviation)
660K
How far from its usual level
+3.7
Same report last year
134K
History used
2,559 days
the 15 Jul 2025 report24 earlier reportsnormal: 1.1M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Financials: Quarterly revenue change became public on 7 Aug 2025
Neuronetics reported revenue of $38.1M for the quarter ended 30 Jun 2025, 2.3× the same quarter last year.
This period
$38.1M (the quarter ended 30 Jun 2025)
Normal quarter (median of 8 earlier)
$18.2M
Typical spread (median absolute deviation)
$1.3M
How far from its usual level
+10.5
Same quarter last year
$16.4M
History used
3,013 days
the quarter ended 30 Jun 20258 earlier quartersnormal: $18.2M
Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.
Institutional holdings: Many funds opening a new position became public on 14 Aug 2025
Neuronetics saw 21 13F filers open a new position in the quarter ended 30 Jun 2025, 3.0× the same quarter last year.
This period
21 (the quarter ended 30 Jun 2025)
Normal quarter (median of 8 earlier)
8
Typical spread (median absolute deviation)
2.5
How far from its usual level
+3.5
Same quarter last year
7
History used
2,557 days
the quarter ended 30 Jun 20258 earlier quartersnormal: 8
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.
Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.
7 Aug 2025Financials change
reported revenue of $38.1M for the quarter ended 30 Jun 2025, 2.3× the same quarter last year.
Same quarter last year: $16.4M; its normal quarter is $18.2M.
See the evidence
This period
$38.1M (the quarter ended 30 Jun 2025)
Normal quarter (median of 8 earlier)
$18.2M
Typical spread (median absolute deviation)
$1.3M
How far from its usual level
+10.5
Same quarter last year
$16.4M
History used
3,013 days
the quarter ended 30 Jun 20258 earlier quartersnormal: $18.2M
Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.
had 4.7M shares sold short in the 15 Jul 2025 report, 35× the same report last year.
Same report last year: 134K; its normal report is 1.1M.
See the evidence
This period
4.7M (the 15 Jul 2025 report)
Normal report (median of 24 earlier)
1.1M
Typical spread (median absolute deviation)
660K
How far from its usual level
+3.7
Same report last year
134K
History used
2,559 days
the 15 Jul 2025 report24 earlier reportsnormal: 1.1M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
saw 55 13F filers open a new position in the quarter ended 31 Mar 2025, 5.0× the same quarter last year.
Same quarter last year: 11; its normal quarter is 7.
See the evidence
This period
55 (the quarter ended 31 Mar 2025)
Normal quarter (median of 8 earlier)
7
Typical spread (median absolute deviation)
2
How far from its usual level
+16.0
Same quarter last year
11
History used
2,466 days
the quarter ended 31 Mar 20258 earlier quartersnormal: 7
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.
had 3.7M shares sold short in the 30 Apr 2025 report, 63× the same report last year.
Same report last year: 58K; its normal report is 586K.
See the evidence
This period
3.7M (the 30 Apr 2025 report)
Normal report (median of 24 earlier)
586K
Typical spread (median absolute deviation)
472K
How far from its usual level
+4.4
Same report last year
58K
History used
2,483 days
the 30 Apr 2025 report24 earlier reportsnormal: 586K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
reported revenue of $32.0M for the quarter ended 31 Mar 2025, 1.8× the same quarter last year; it also had 3.7M shares sold short in the 30 Apr 2025 report, 63× the same report last year; and it saw 55 13F filers open a new position in the quarter ended 31 Mar 2025, 5.0× the same quarter last year. Three unrelated kinds of activity within 30 days.
See the evidence (5 changes)
Short interest and volume: Short interest spike became public on 10 Apr 2025
Neuronetics had 3.3M shares sold short in the 31 Mar 2025 report, 35× the same report last year.
This period
3.3M (the 31 Mar 2025 report)
Normal report (median of 24 earlier)
560K
Typical spread (median absolute deviation)
446K
How far from its usual level
+4.2
Same report last year
95K
History used
2,453 days
the 31 Mar 2025 report24 earlier reportsnormal: 560K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Short interest and volume: Short interest spike became public on 26 Apr 2025
Neuronetics had 3.4M shares sold short in the 15 Apr 2025 report, 60× the same report last year.
This period
3.4M (the 15 Apr 2025 report)
Normal report (median of 24 earlier)
564K
Typical spread (median absolute deviation)
450K
How far from its usual level
+4.3
Same report last year
58K
History used
2,468 days
the 15 Apr 2025 report24 earlier reportsnormal: 564K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Financials: Quarterly revenue change became public on 8 May 2025
Neuronetics reported revenue of $32.0M for the quarter ended 31 Mar 2025, 1.8× the same quarter last year.
This period
$32.0M (the quarter ended 31 Mar 2025)
Normal quarter (median of 8 earlier)
$17.7M
Typical spread (median absolute deviation)
$1.0M
How far from its usual level
+8.0
Same quarter last year
$17.4M
History used
2,922 days
the quarter ended 31 Mar 20258 earlier quartersnormal: $17.7M
Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.
Short interest and volume: Short interest spike became public on 10 May 2025
Neuronetics had 3.7M shares sold short in the 30 Apr 2025 report, 63× the same report last year.
This period
3.7M (the 30 Apr 2025 report)
Normal report (median of 24 earlier)
586K
Typical spread (median absolute deviation)
472K
How far from its usual level
+4.4
Same report last year
58K
History used
2,483 days
the 30 Apr 2025 report24 earlier reportsnormal: 586K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Institutional holdings: Many funds opening a new position became public on 15 May 2025
Neuronetics saw 55 13F filers open a new position in the quarter ended 31 Mar 2025, 5.0× the same quarter last year.
This period
55 (the quarter ended 31 Mar 2025)
Normal quarter (median of 8 earlier)
7
Typical spread (median absolute deviation)
2
How far from its usual level
+16.0
Same quarter last year
11
History used
2,466 days
the quarter ended 31 Mar 20258 earlier quartersnormal: 7
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.
Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.
8 May 2025Financials change
reported revenue of $32.0M for the quarter ended 31 Mar 2025, 1.8× the same quarter last year.
Same quarter last year: $17.4M; its normal quarter is $17.7M.
See the evidence
This period
$32.0M (the quarter ended 31 Mar 2025)
Normal quarter (median of 8 earlier)
$17.7M
Typical spread (median absolute deviation)
$1.0M
How far from its usual level
+8.0
Same quarter last year
$17.4M
History used
2,922 days
the quarter ended 31 Mar 20258 earlier quartersnormal: $17.7M
Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.
had 3.4M shares sold short in the 15 Apr 2025 report, 60× the same report last year.
Same report last year: 58K; its normal report is 564K.
See the evidence
This period
3.4M (the 15 Apr 2025 report)
Normal report (median of 24 earlier)
564K
Typical spread (median absolute deviation)
450K
How far from its usual level
+4.3
Same report last year
58K
History used
2,468 days
the 15 Apr 2025 report24 earlier reportsnormal: 564K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 3.3M shares sold short in the 31 Mar 2025 report, 35× the same report last year.
Same report last year: 95K; its normal report is 560K.
See the evidence
This period
3.3M (the 31 Mar 2025 report)
Normal report (median of 24 earlier)
560K
Typical spread (median absolute deviation)
446K
How far from its usual level
+4.2
Same report last year
95K
History used
2,453 days
the 31 Mar 2025 report24 earlier reportsnormal: 560K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 2.8M shares sold short in the 14 Mar 2025 report, 52× the same report last year.
Same report last year: 53K; its normal report is 521K.
See the evidence
This period
2.8M (the 14 Mar 2025 report)
Normal report (median of 24 earlier)
521K
Typical spread (median absolute deviation)
419K
How far from its usual level
+3.6
Same report last year
53K
History used
2,436 days
the 14 Mar 2025 report24 earlier reportsnormal: 521K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Showing the newest 40 of 141 entries; narrow the window or the kind of data to see older ones.
Not listed: 203 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.
Identifiers and sources
How records are matched to this company, and what each source holds for it
Cik
0001227636
Ticker
STIM
Domain
neurostar.com
Hq location
PA|MALVERN|19355 (1 unverified)
Lobbying client
neuronetics
Name
Neuronetics, Inc.
Uei
Z7KADU9Q2DG8
Wikidata
Q7002474
Wikipedia
Neuronetics
Federal lobbying disclosures (LDA)3 records, 22 data points14 Sep 2023 to 30 Sep 2026
SEC Form 13F institutional holdings306 data points30 Jun 2018 to 30 Sep 2026
SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)154 records13 Jun 2017 to 12 Nov 2026
SEC XBRL company facts (revenue, capex, R&D, backlog...)724 data points31 Dec 2015 to 28 Oct 2026
SEC Form 4 insider transactions148 records, 464 data points5 Jul 2018 to 13 Nov 2026
FINRA short interest (twice monthly)596 data points13 Jul 2018 to 30 Oct 2026
FINRA daily short sale volume (off-exchange)4178 data points1 Aug 2018 to 20 Nov 2026
USASpending.gov federal awards840 data points2 Jan 2009 to 2 Jun 2026
Wikipedia pageviews2881 data points1 Jan 2019 to 20 Nov 2026